Welcome to LookChem.com Sign In|Join Free
  • or
Pyrrolidine, 3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-, (3S)is a heterocyclic organic compound with a molecular formula of C11H25NO2Si. It is a derivative of pyrrolidine, which features a five-membered ring composed of four carbon atoms and one nitrogen atom. The (3S)configuration highlights its stereochemistry, with the "S" indicating the absolute configuration of the highest numbered chiral center in the molecule. Pyrrolidine, 3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-, (3S)also incorporates a tert-butyldimethylsilyloxy group, which serves as a protecting group in organic synthesis to shield specific functional groups from unwanted reactions. Its unique structure and properties make it a valuable compound for applications in organic synthesis, medicinal chemistry, and other scientific fields.

207113-36-8

Post Buying Request

207113-36-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

207113-36-8 Usage

Uses

Used in Organic Synthesis:
Pyrrolidine, 3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-, (3S)is used as a protecting group in organic synthesis for preventing unwanted reactions at specific functional groups. Its tert-butyldimethylsilyloxy group allows chemists to temporarily block certain sites on a molecule, facilitating the selective synthesis of complex organic compounds.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, Pyrrolidine, 3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-, (3S)may be utilized as a building block or intermediate in the development of pharmaceutical compounds. Its unique structure and stereochemistry can contribute to the design of novel drugs with specific biological activities and therapeutic properties.
Used in Scientific Research:
Pyrrolidine, 3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-, (3S)can also be employed in various scientific research applications, such as studying the synthesis and reactivity of heterocyclic compounds, investigating the properties of chiral molecules, and exploring the use of protecting groups in organic synthesis. Its versatile nature and potential applications make it an interesting compound for researchers in multiple scientific disciplines.

Check Digit Verification of cas no

The CAS Registry Mumber 207113-36-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,7,1,1 and 3 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 207113-36:
(8*2)+(7*0)+(6*7)+(5*1)+(4*1)+(3*3)+(2*3)+(1*6)=88
88 % 10 = 8
So 207113-36-8 is a valid CAS Registry Number.

207113-36-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name (S)-3-((tert-butyldimethylsilyl)oxy)pyrrolidine

1.2 Other means of identification

Product number -
Other names (S)-3-(tert-Butyl-dimethyl-silanyloxy)-pyrrolidine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:207113-36-8 SDS

207113-36-8Relevant academic research and scientific papers

SIX-MEMBERED AND SIX-MEMBERED HETEROCYCLIC COMPOUND AND USES THEREOF SERVING AS PROTEIN RECEPTOR KINASE INHIBITOR

-

Paragraph 0369-0372, (2021/09/24)

Provided are a preparation and applications of a six-membered fused with six-membered heterocyclic compound, specifically, provided in the present invention is a compound as represented by formula I as follows, where the definitions of the groups are as described in the description. The compound has TRK kinase inhibiting activity and can serve as a pharmaceutical composition for treating TRK dysfunction-related diseases.

SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1

-

Paragraph 00552, (2016/04/26)

Provided herein are small molecule neurotensin receptor agonists, compositions comprising the compounds, and methods of using the compounds and compositions comprising the compounds.

SUBSTITUTED HETEROCYCLIC ACETAMIDES AS KAPPA OPIOID RECEPTOR (KOR) AGONISTS

-

Page/Page column 107; 108, (2013/09/26)

The present invention relates to a series of substituted compounds having the general formula (I), including their ste reoisomers and/or their pharmaceutically acceptable salts, wherein R1, R2, R3. R4, R5, and R6 are as defined herein. This invention also relates to methods of making these compounds including intermediates. The compounds of this invention are effective at the kappa (κ) opioid receptor (KOR) site. Therefore, the compounds of this invention are useful as pharmaceutical agents, especially in the treatment and/or prevention of a variety of central nervous system disorders (CNS), including but not limited to acute and chronic pain, and associated disorders, particularly functioning peripherally at the CNS.

Regioselective synthesis of nitrones by decarboxylative oxidation of N- alkyl-α-amino acids and application to the synthesis of 1-azabicyclic alkaloids

Ohtake, Hiroaki,Imada, Yasushi,Murahashi, Shun-Ichi

, p. 2737 - 2754 (2007/10/03)

Tungstate-catalyzed oxidation of N-alkyl-2a-amino acids with 30% H2O2 solution under phase-transfer conditions gives nitrones regioselectively in good yields: Using this method, stereodivergent synthesis of (R)- and (S)-4- (t-butyldimethylsilyloxy)-1-pyrroline N-oxides ((R)-17a and (S)-17a) was achieved. In addition, (R)- and (S)-3-(t-butyldimethylsilyloxy)-1-pyrroline N-oxides ((R)-45 and (S)-45) were prepared by catalytic oxidation of the corresponding chiral pyrrolidines in a regioselective manner. These chiral cyclic nitrones, 17 and 45 are versatile intermediates for the synthesis of optically active nitrogen heterocycles, since stereoselective additions of carbon nucleophiles to these chiral nitrones can be readily performed. Typically, ZnI2-mediated addition of ketene t-butyldimethylsilyi methyl acetal (29a): to (R)-17a gave the' cis-adduct, methyl (2R,4R)-[1,4-bis(t- butyldimethylsilyloxy)pyrrolidin-2-yl]acetate (cis-30). In contrast, the addition of lithium acetylides 34 to the nitrone (R)-17a gave the trans- adducts, (2S,4R)-2-(1-alkynyl)-4-(t-butyldimethylsilyloxy)-1- hydroxypyrrolidines trans-35. These adducts are useful intermediates for syntheses of the nitrogen heterocycles (3R,5R)-1-aza-3- hydroxybicyclo[3.3.0]octane (37) and (6R,8R)-1-aza-8- hydroxybicyclo[4.30]nonane (38), respectively. The ZnI2-mediated addition of ketene silyl acetal 29a to the nitrone (R)-45 gave methyl (2S, 3R)-[1,3- bis(t-butyldimethylsilyloxy)pyrrolidin-2-yl]acetate (trans-50a), which was used for asymmetric synthesis of the Geissman-Waiss lactone ((-)-49).

Synthesis of (R)- and (S)-3-(tert-butyldimethylsilyloxy)-1-pyrroline N- oxides - Chiral nitrones for synthesis of biologically active pyrrolidine derivative, Geissman-Waiss lactone

Murahashi, Shun-Ichi,Ohtake, Hiroaki,Imada, Yasushi

, p. 2765 - 2766 (2007/10/03)

Tungstate-catalyzed oxidation of O-tert-butyldimethylsilyl (O-TBDMS) protected (R)-3-hydroxypyrrolidine ((R)2), derived from trans-4-hydroxy-L- proline, gave O-TBDMS protected (R)-3-hydroxy-1-pyrroline N-oxide ((R)1), which is a new chiral precursor for the synthesis of Geissman-Waiss lactone. The enantiomeric nitrone (S)-1 was also prepared by the oxidation of (S)-2 derived from L-malic acid.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 207113-36-8